Staking Ground in Orthopedics
Executive SummaryManaged care is forcing suppliers and their customers into new and sometimes difficult alliances. Just a couple of years ago, few US hospitals had programs in place that reduced orthopedic implant costs through standardization and other product management strategies. If this year's Technology Futures Panel on Orthopedics sponsored by Premier Health Alliance is any indication, it seems not having such a program is the exception today.
You may also be interested in...
December's ANDA rush has provided the largest monthly haul in two years. However, the month may be losing its influence over the US FDA's annual submission total.
Among the Korean firms presenting at J.P. Morgan, Hanmi laid out its strategy for obesity and other core pipeline assets, Celltrion focused on its expanding biosimilar pipeline and China plans and LG Chem unveiled new R&D progress.